Merck & Co. Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Merck & Co. (MRK) shares rose 1.98% to $135.55, hitting a new 52-week high and outperforming competitors like Johnson & Johnson, Pfizer, and Eli Lilly on August 13, 2026. This marked the second consecutive day of gains for Merck, contributing to a positive trading session where the S&P 500 and Dow Jones also advanced.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Merck & Co. Inc. (MRK) advanced 1.98% to $135.55 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.65% to 7,798.99 and the Dow Jones Industrial Average rising 0.13% to 53,839.99.
This was the stock's second consecutive day of gains.
Merck & Co. Inc. hit a new 52-week high, surpassing its previous peak of $135.05, which the company reached on July 28th.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 0.47% to $262.08, Pfizer Inc. (PFE) rose 1.86% to $26.80, and Eli Lilly & Co. (LLY) fell 0.92% to $1,209.00.
Trading volume (8.9 M) remained 1.5 million below its 50-day average volume of 10.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 13, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-13-26 1633ET